Dimensional Fund Advisors
ZVRA icon

Dimensional Fund Advisors’s Zevra Therapeutics ZVRA Stock Holding History

Dimensional Fund Advisors’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.3M Buy
1,116,541
+157,705
+16% +$1.87M ﹤0.01% 2209
2026
Q2 		$13.7M Buy
958,836
+404,034
+73% +$4.49M ﹤0.01% 2180
2026
Q1 		$5.17M Buy
554,802
+400,336
+259% +$3.61M ﹤0.01% 2486
2025
Q4 		$1.38M Buy
+154,466
New +$1.46M ﹤0.01% 2807
2024
Q4 		– Sell
-24,800
Closed -$172K – 3369
2024
Q3 		$172K Sell
24,800
-1,144
-4% -$7.76K ﹤0.01% 3191
2024
Q2 		$127K Hold
25,944
– – ﹤0.01% 3220
2024
Q1 		$150K Sell
25,944
-17,661
-41% -$109K ﹤0.01% 3219
2023
Q4 		$286K Sell
43,605
-10,285
-19% -$48.1K ﹤0.01% 3142
2023
Q3 		$260K Buy
53,890
+8
+0% +$40 ﹤0.01% 3166
2023
Q2 		$275K Hold
53,882
– – ﹤0.01% 3179
2023
Q1 		$296K Buy
+53,882
New +$285K ﹤0.01% 3125
2022
Q3 		$329K Buy
52,722
+1,064
+2% +$6.03K ﹤0.01% 3141
2022
Q2 		$230K Buy
+51,658
New +$235K ﹤0.01% 3233

Other funds holding ZVRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Integrity Alliance
Integrity Alliance Urbandale, Iowa $3.28B AUM 15.79% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Retirement Planning Company of New England
Retirement Planning Company of New England Warwick, Rhode Island $263M AUM 26.23% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
MAM
Mystic Asset Management Warwick, Rhode Island $451M AUM 22.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

Dimensional Fund Advisors's ZVRA Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Zevra Therapeutics (ZVRA) stake by 16% in Q3 2026, buying an estimated $1.87M and bringing the position to 1,116,541 shares worth $12.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2209.

Dimensional Fund Advisors first reported a position in ZVRA in Q2 2022 and has held it in 13 quarters since. The position peaked at $13.7M in Q2 2026. 59 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.

  • Dimensional Fund Advisors held 1,116,541 shares of Zevra Therapeutics worth $12.3M as of Q3 2026.
  • Dimensional Fund Advisors bought 157,705 Zevra Therapeutics shares in Q3 2026, an estimated $1.87M.
  • Zevra Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2209 holding.
  • Dimensional Fund Advisors first reported a position in Zevra Therapeutics in Q2 2022 and has held it in 13 quarters since.
  • Dimensional Fund Advisors's Zevra Therapeutics position peaked at $13.7M in Q2 2026.
  • 59 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.